Yaz and Yasmin Lawsuits Continue to Settle
According to recent news reports, the number of settled Yaz and Yasmin lawsuits has reached about 1,500. This is up from a previous report from a stockholders’ newsletter from the first quarter of 2012, which indicated that Bayer had agreed to pay $142 million to settle 651 lawsuits. It is estimated that there are approximately 11,500 personal injury suits that have been lodged against Bayer, the manufacturer of Yaz and Yasmin.
The majority of lawsuits that have settled involve claimants who experienced serious blood clots, including pulmonary embolism and deep vein thrombosis. According to Stephen Saltzburg, special master of this MDL, the average settlement at this stage is approximately $214,000.
These lawsuits allege that Bayer failed to adequately warn consumers about the drugs' potentially fatal side effects, including the risk of blood clots, pulmonary embolism, and gallbladder disease. On April 10th, 2012, the FDA ordered Bayer and other contraceptive manufacturers to amend the blood-clot warnings on their labels. For drospirenone-containing pills such as Yaz and Yasmin, warning labels must state that researchers have found they may triple the risk for blood clots.
About the Author:
David Smethie is a Deal Origination Manager at RD Legal Funding, a leading lawsuit financing company that specializes in post-settlement legal funding. RD Legal has offices in New Jersey and California. You can contact RD Legal at 1-800-565-5177.